We all know that a diet lacking in nutrition leads to poor health — but scientists have now studied the impact on mice who…
Sleep seems to play a big — though still mysterious — role in brain health. And mounting research is pointing to a strong link…
The brain’s neurons communicate with each other through chemical and electrical signals. But as Alzheimer’s disease develops, protein plaques and deposits buildup and kill…
Today, more than 55 million people are living with Alzheimer’s disease globally. In the U.S., one in 10 people over the age of 65,…
Scientists still aren’t sure what causes Alzheimer’s, but they have figured out that the progression of this disease is closely linked to the buildup…
After almost two decades of stagnation, two new drugs for Alzheimer’s have hit the market in the last three years. The approval of Biogen…
Sure, your run-of-the-mill, every day stress and worry may be associated with dementia. But just as depression bears a well-known link to dementia, including…
Despite decades of study, the underlying cause of Alzheimer’s continues to evade scientists. Because it’s such a mystery, there are only six drugs approved for…
Over 30 million people live with Alzheimer’s disease worldwide, making it the most common form of dementia. Two thirds of those diagnoses are women….
As Julie Fleming’s father slipped into the later stages of Alzheimer’s dementia, she could only watch as his computer skills and interests faded. “The…
A 19-year-old man from China, who has been having memory problems since the age of 17, was diagnosed with dementia, according to a recent…
Siesta. Power nap. Forty winks. Call them what you will: Naps have been found to benefit mood, alertness, energy levels, cognitive performance, and, in…
Early this year, the Food and Drug Administration (FDA) granted accelerated approval to a new anti-amyloid treatment developed by Eisai and Biogen, Leqembi. In…
Anna Karenina begins with the famous line: “Happy families are all alike; every unhappy family is unhappy in its own way.” The principle holds…
Recently, Eli Lilly announced that their anti-amyloid drug solanezumab failed to prevent Alzheimer’s in cognitively healthy older individuals who showed amyloid plaque accumulation in…